Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioclonet is a South Korean biotechnology company specializing in the development and manufacture of high-quality antibodies, recombinant proteins, and rapid diagnostic kits. The company focuses on providing critical raw materials and finished diagnostic solutions for various medical conditions, including infectious diseases, cardiovascular disorders, and inflammatory markers. Bioclonet's product portfolio includes point-of-care testing (POCT) reagents and raw materials such as monoclonal antibodies and antigens used by other diagnostic manufacturers globally. By leveraging its expertise in protein engineering and immunology, the company supports both clinical diagnostics and life science research applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioclonet.